Expression of PD1 and BTLA on the CD8<sup>+</sup> T Cell  and γδT Cell Subsets in Peripheral Blood of  Non-Small Cell Lung Cancer Patients

Bao Yi; Mo Juanfen; Wu Jiayuan; Cao Chenxi

doi:10.24920/003498

Your Location：

Home >

Browse articles >

Expression of PD1 and BTLA on the CD8⁺ T Cell and γδT Cell Subsets in Peripheral Blood of Non-Small Cell Lung Cancer Patients

Chinese Medical Sciences Journal Vol. 34, Issue 4, Pages: 248-255(2019)

Original Article | Updated：2024-04-10

- Expression of PD1 and BTLA on the CD8⁺ T Cell and γδT Cell Subsets in Peripheral Blood of Non-Small Cell Lung Cancer Patients
- Affiliations：
  
  1. Central Laboratory, The Second Hospital of Jiaxing City, Jiaxing, Zhejiang 314000, China
  2. Department of Oncology, The Second Hospital of Jiaxing City, Jiaxing, Zhejiang 314000, China
- Author bio：
  
  *E-mail: ybao2011@gmail.com; Tel: 86-0573-82073185.
- Funds：
- DOI：10.24920/003498
  CLC：
- Received：28 August 2018，
  
  Accepted：2018-10-22，
  
  Published Online：06 December 2019，
  
  Published：06 December 2019
- Accepted：
Scan QR Code
Bao Yi, Mo Juanfen, Wu Jiayuan, et al. Expression of PD1 and BTLA on the CD8⁺ T Cell and γδT Cell Subsets in Peripheral Blood of Non-Small Cell Lung Cancer Patients[J]. Chinese medical sciences journal, 2019, 34(4): 248-255.
DOI：

Bao Yi, Mo Juanfen, Wu Jiayuan, et al. Expression of PD1 and BTLA on the CD8⁺ T Cell and γδT Cell Subsets in Peripheral Blood of Non-Small Cell Lung Cancer Patients[J]. Chinese medical sciences journal, 2019, 34(4): 248-255. DOI： 10.24920/003498.

摘要

Abstract

关键词

Keywords

references

Bray F , Ferlay J , Soerjomataram I , et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries . CA Cancer J Clin 2018 ; 68 ( 6 ): 394 - 424 . doi: 10.3322/caac.21492 1001-9294-34-4-248/caac.21492 .

Moon EK , Langer CJ , Albelda SM . The era of checkpoint blockade in lung cancer: taking the brakes off the immune system . Ann Am Thorac Soc 2017 ; 14 ( 8 ): 1248 - 60 . doi: 10.1513/AnnalsATS.201702-152FR 1001-9294-34-4-248/AnnalsATS.201702-152FR .

Cruz MS , Diamond A , Russell A , et al . Human alphabeta and gammadelta T cells in skin immunity and disease . Front Immunol 2018 ; 9 : 1304 . doi: 10.3389/fimmu.2018.01304 1001-9294-34-4-248/fimmu.2018.01304 .

Chien YH , Meyer C , Bonneville M . Gammadelta T cells: first line of defense and beyond . Annu Rev Immunol 2014 ; 32 : 121 - 55 . doi: 10.1146/annurev-immunol-032713-120216 1001-9294-34-4-248/annurev-immunol-032713-120216 .

Urban EM , Chapoval AI , Pauza CD . Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells . Clin Dev Immunol 2010 ; 2010 : 732893 . doi: 10.1155/2010/732893 1001-9294-34-4-248/2010/732893 .

Rudd CE , Taylor A , Schneider H . CD28 and CTLA-4 coreceptor expression and signal transduction . Immunol Rev 2009 ; 229 ( 1 ): 12 - 26 . doi: 10.1111/j.1600-065X.2009.00770.x 1001-9294-34-4-248/j.1600-065X.2009.00770.x .

Chikuma S . CTLA-4, an essential immune-checkpoint for T-cell activation . Curr Top Microbiol Immunol 2017 ; 410 : 99 - 126 . doi: 10.1007/82_2017_61 1001-9294-34-4-248/82_2017_61 .

Chen L , Flies DB . Molecular mechanisms of T cell co-stimulation and co-inhibition . Nat Rev Immunol 2013 ; 13 ( 4 ): 227 - 42 . doi: 10.1038/nri3405 1001-9294-34-4-248/nri3405 .

Edge SB , Compton CC . The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM . Ann Surg Oncol 2010 ; 17 ( 6 ): 1471 - 4 . doi: 10.3322/caac.21388 1001-9294-34-4-248/caac.21388 .

Chen L . Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity . Nat Rev Immunol 2004 ; 4 ( 5 ): 336 - 47 . doi: 10.1038/nri1349 1001-9294-34-4-248/nri1349 .

Riley JL . PD-1 signaling in primary T cells . Immunol Rev 2009 ; 229 ( 1 ): 114 - 25 . doi: 10.1111/j.1600-065X.2009.00767.x 1001-9294-34-4-248/j.1600-065X.2009.00767.x .

Kulpa DA , Lawani M , Cooper A , et al . PD-1 coinhibitory signals: the link between pathogenesis and protection . Semin Immunol 2013 ; 25 ( 3 ): 219 - 27 . doi: 10.1016/j.smim.2013.02.002 1001-9294-34-4-248/j.smim.2013.02.002 .

Hall RD , Gray JE , Chiappori AA . Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer . Cancer Control 2013 ; 20 ( 1 ): 22 - 31 . doi: 10.1177/107327481302000105 1001-9294-34-4-248/107327481302000105 .

Pasero C , Speiser DE , Derre L , et al . The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy . Curr Opin Pharmacol 2012 ; 12 ( 4 ): 478 - 85 . doi: 10.1016/j.coph.2012.03.001 1001-9294-34-4-248/j.coph.2012.03.001 .

Wherry EJ , Kurachi M . Molecular and cellular insights into T cell exhaustion . Nat Rev Immunol 2015 ; 15 ( 8 ): 486 - 99 . doi: 10.1038/nri3862 1001-9294-34-4-248/nri3862 .

Gertner-Dardenne J , Fauriat C , Orlanducci F , et al . The co-receptor BTLA negatively regulates human Vgamma9Vdelta2 T-cell proliferation: a potential way of immune escape for lymphoma cells . Blood 2013 ; 122 ( 6 ): 922 - 31 . doi: 10.1182/blood-2012-11-464685 1001-9294-34-4-248/blood-2012-11-464685 .

Watanabe N , Gavrieli M , Sedy JR , et al . BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 . Nat Immunol 2003 ; 4 ( 7 ): 670 - 9 . doi: 10.1038/ni944 1001-9294-34-4-248/ni944 .

Pasero C , Olive D . Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity . Immunol Lett 2013 ; 151 ( 1-2 ): 71 - 5 . doi: 10.1016/j.imlet.2013.01.008 1001-9294-34-4-248/j.imlet.2013.01.008 .

Ware CF , Sedy JR . TNF superfamily networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14) . Curr Opin Immunol 2011 ; 23 ( 5 ): 627 - 31 . doi: 10.1016/j.coi.2011.08.008 1001-9294-34-4-248/j.coi.2011.08.008 .

Radvanyi LG , Bernatchez C , Zhang M , et al . Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients . Clin Cancer Res 2012 ; 18 ( 24 ): 6758 - 70 . doi: 10.1158/1078-0432.CCR-12-1177 1001-9294-34-4-248/1078-0432.CCR-12-1177 .

Lou Y , Diao L , Cuentas ER , et al . Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma . Clin Cancer Res 2016 ; 22 ( 14 ): 3630 - 42 . doi: 10.1158/1078-0432.CCR-15-1434 1001-9294-34-4-248/1078-0432.CCR-15-1434 .

Beetz S , Wesch D , Marischen L , et al: Innate immune functions of human gammadelta T cells . Immunobiology 2008 ; 213 ( 3-4 ): 173 - 82 . doi: 10.1016/j.imbio.2007.10.006 1001-9294-34-4-248/j.imbio.2007.10.006 .

Marten A , Lilienfeld-Toal M , Buchler MW , et al . Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for delta2 gamma/delta T cells . J Immunother 2007 ; 30 ( 4 ): 370 - 7 . doi: 10.1097/CJI.0b013e31802bff16 1001-9294-34-4-248/CJI.0b013e31802bff16 .

Lipton A , Cook RJ , Major P , et al . Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity . Oncologist 2007 ; 12 ( 9 ): 1035 - 43 . doi: 10.1634/theoncologist.12-9-1035 1001-9294-34-4-248/theoncologist.12-9-1035 .

Views

732

Downloads

CSCD

Alert me when the article has been cited

Submit

Publicity Resources

Bevacizumab Combined with Icotinib Overcomes Osimertinib Resistance in a Patient of Non-Small Cell Lung Cancer

Related Author

Zhang Ling

Sun Lei

Mu Xiaoyan

Ji Youxin

Related Institution

Department of Oncology, Qingdao Cancer Hospital

Department of Oncology, the Affiliated Qingdao Central Hospital, Qingdao University

⁰

Expression of PD1 and BTLA on the CD8+ T Cell and γδT Cell Subsets in Peripheral Blood of Non-Small Cell Lung Cancer Patients

DOI：10.24920/003498

摘要

Abstract

关键词

Keywords

references

Expression of PD1 and BTLA on the CD8⁺ T Cell and γδT Cell Subsets in Peripheral Blood of Non-Small Cell Lung Cancer Patients